Ferritin Testing Market Size & Share, by Product Type (Instrument, Reagent, Kits); Indication (Anemia, Hemochromatosis, Pregnancy, Lead Poisoning); End-user (Hospitals, Diagnostic Laboratories, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4137
  • Published Date: May 01, 2023
  • Report Format: PDF, PPT

Companies Dominating the Ferritin Testing Landscape

top-features-companies
    • Sekisui Diagnostics, LLC. 
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • bioMérieux SA
    • Thermo Fisher Scientific Inc.
    • ORGENTEC Diagnostika GmbH
    • Eurolyser Diagnostica GmbH
    • Cortez Diagnostics Inc.
    • HORIBA Ltd.
    • Monobind Inc.
    • Aviva Systems Biology Corporation
    • Abnova Corporation

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • bioMérieux, a global leader in in-vitro diagnostics, has completed the acquisition of Specific Diagnostics, which has developed a rapid antimicrobial susceptibility test (AST) system that generates phenotypic AST directly from positive blood cultures.
  • HORIBA Ltd. expands its laboratory Chemistry products by acquiring MedTest Dx and Pointe Scientific. With the addition of Pointe Scientific's complementary novel technology and MedTest's high-quality Chemistry solutions, HORIBA Medical is expected to fulfill the diverse needs of the In-vitro diagnostics market.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4137
  • Published Date: May 01, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The rise in geriatric population all across the globe, and less awareness of iron deficiency across the globe are the major factors driving the growth of the ferritin testing market.

The market size of ferritin testing is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2035.

The major players in the market are Sekisui Diagnostics, LLC., BioM�rieux, Thermo Fisher Scientific Inc., Eurolyser Diagnostics GmbH, HORIBA Ltd., Monobind, Aviva Systems Biology, and Abnova.

The anemia segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

North America is estimated to create notable growth opportunities for market growth over the forecast period.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying